You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信達生物-B(01801.HK)完成配售9700萬股 淨籌23.51億港元
格隆匯 10-18 20:29

格隆匯10月18日丨信達生物-B(01801.HK)發佈公告,配售事項已於2019年10月9日完成。合共9700萬股配售股份已按配售價每股24.60港元成功配發予不少於六名承配人。

由於認購事項的所有條件已獲達成,公司已於2019年10月18日按每股認購股份24.60港元向賣方配發及發行9700萬股認購股份。認購事項的所得款項淨額約為23.5133億港元。

此外,公司澄清,認購股份根據一般授權發行,該授權根據於2019年6月14日舉行的公司股東周年大會上經公司股東批准通過的普通決議案授予董事,可配發、發行及處理不超過約2.31億股股份。緊隨配售事項及認購事項完成後,公司仍可根據一般授權配發、發行及處理不超過約1.34億股股份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account